BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12223527)

  • 1. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
    Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
    J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3.
    Xu B; Bhattacharjee A; Roy B; Xu HM; Anthony D; Frank DA; Feldman GM; Cathcart MK
    Mol Cell Biol; 2003 Jun; 23(11):3918-28. PubMed ID: 12748293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members.
    Jiang Q; Li WQ; Hofmeister RR; Young HA; Hodge DR; Keller JR; Khaled AR; Durum SK
    Mol Cell Biol; 2004 Jul; 24(14):6501-13. PubMed ID: 15226449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma.
    Liu H; Jacobs BS; Liu J; Prayson RA; Estes ML; Barnett GH; Barna BP
    Cancer Immunol Immunother; 2000 Aug; 49(6):319-24. PubMed ID: 10946814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells.
    Kawakami M; Kawakami K; Puri RK
    Cancer Immunol Immunother; 2002 Feb; 50(12):691-700. PubMed ID: 11862421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction and activation of gene transcription by interferons.
    Gilmour KC; Reich NC
    Gene Expr; 1995; 5(1):1-18. PubMed ID: 7488857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct functional programming of human fetal and adult monocytes.
    Krow-Lucal ER; Kim CC; Burt TD; McCune JM
    Blood; 2014 Mar; 123(12):1897-904. PubMed ID: 24518760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages.
    Bhattacharjee A; Shukla M; Yakubenko VP; Mulya A; Kundu S; Cathcart MK
    Free Radic Biol Med; 2013 Jan; 54():1-16. PubMed ID: 23124025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-13 receptors and signaling pathways: an evolving web.
    Hershey GK
    J Allergy Clin Immunol; 2003 Apr; 111(4):677-90; quiz 691. PubMed ID: 12704343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.
    LaPorte SL; Juo ZS; Vaclavikova J; Colf LA; Qi X; Heller NM; Keegan AD; Garcia KC
    Cell; 2008 Jan; 132(2):259-72. PubMed ID: 18243101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics and interaction of interleukin-4 receptor subunits in living cells.
    Gandhi H; Worch R; Kurgonaite K; Hintersteiner M; Schwille P; Bökel C; Weidemann T
    Biophys J; 2014 Dec; 107(11):2515-27. PubMed ID: 25468331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
    Andrews AL; Holloway JW; Holgate ST; Davies DE
    J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling mechanisms, interaction partners, and target genes of STAT6.
    Hebenstreit D; Wirnsberger G; Horejs-Hoeck J; Duschl A
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):173-88. PubMed ID: 16540365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation.
    Seki Y; Hayashi K; Matsumoto A; Seki N; Tsukada J; Ransom J; Naka T; Kishimoto T; Yoshimura A; Kubo M
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13003-8. PubMed ID: 12242343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-4 and interleukin-13: their similarities and discrepancies.
    Chomarat P; Banchereau J
    Int Rev Immunol; 1998; 17(1-4):1-52. PubMed ID: 9914942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interleukin-4-induced transcription factor: IL-4 Stat.
    Hou J; Schindler U; Henzel WJ; Ho TC; Brasseur M; McKnight SL
    Science; 1994 Sep; 265(5179):1701-6. PubMed ID: 8085155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions.
    Sarapultsev A; Gusev E; Komelkova M; Utepova I; Luo S; Hu D
    Mol Biomed; 2023 Nov; 4(1):40. PubMed ID: 37938494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.
    Mahjoor M; Mahmoudvand G; Farokhi S; Shadab A; Kashfi M; Afkhami H
    Cell Commun Signal; 2023 Oct; 21(1):272. PubMed ID: 37784164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
    Valle-Mendiola A; Gutiérrez-Hoya A; Soto-Cruz I
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy.
    Knudson KM; Hwang S; McCann MS; Joshi BH; Husain SR; Puri RK
    Front Immunol; 2022; 13():878365. PubMed ID: 35464460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.